Drugs / VP 20629
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01898884 | Aug 2013 → Jun 2015 | Friedreich ataxia | Shire | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VP 20629 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01898884 ↗ |
| Route | Oral | “multiple oral doses of VP 20629” NCT01898884 ↗ |